IP Library Granted Patent US 7,442,548
Granted Patent B2
US 7,442,548 · App. 11/221,516 · Granted Oct 28, 2008

Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid

Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,442,548
App. No.
11/221,516
Granted
Oct 28, 2008
Kind
B2
Abstract

Previous methods for culturing human embryonic stem cells have required either fibroblast feeder cells or a medium which has been exposed to fibroblast feeder cells in order to maintain the stem cells in an undifferentiated state. It has now been found that if high levels of fibroblast growth factor are used in a medium with gamma amino butyric acid, pipecholic acid, lithium and lipids, the stem cells will remain undifferentiated indefinitely through multiple passages, even without feeder cells or conditioned medium. A humanized matrix of human proteins can be used as a basement matrix to culture the cells. New lines of human embryonic stem cells made using these culture conditions, the medium and the matrix, will never have been exposed to animal cells, animal products, feeder cells or conditioned medium.

Claims (19)

1. A method for initiating a new cultured line of human embryonic stem cells without the use of feeder cells or conditioned medium, the method comprising the step of

plating cells from a blastocyst onto a matrix in a medium including albumin, minerals, vitamins, amino acids, glucose, a fibroblast growth factor, gamma amino butyric acid, pipecholic acid, lithium, lipids, a transferrin or a transferrin substitute and insulin or an insulin substitute in sufficient amounts to originate and maintain a new proliferating stem cell line in an undifferentiated state.

2. The method of claim 1 wherein the medium includes the fibroblast growth factor in a concentration of at least 40 ng/ml.

3. An in vitro cell culture comprising in a culture vessel:

human embryonic stem cells;

a culture medium, the culture medium comprising albumin, minerals, salts, vitamins, amino acids, glucose, a fibroblast growth factor, gamma amino butyric acid, pipecholic acid, lithium, lipids, a transferrin or a transferrin substitute and insulin or an insulin substitute in sufficient amounts to maintain the stem cells in an undifferentiated state through multiple culture passages, the medium being free of feeder cells and never having been exposed to feeder cells; and

a humanized matrix made from human collagen and at least two of human proteins selected from fibronectin, vitronectin and laminin.

4. The culture of claim 3 wherein the matrix includes all of collagen, fibronectin, vitronectin and laminin.

5. The culture of claim 3 wherein the medium includes the fibroblast growth factor in a concentration of at least 40 ng/ml.

6. An in vitro cell culture comprising in a culture vessel:

human embryonic stem cells;

a humanized matrix made from human collagen and at least two of the human proteins selected from fibronectin, vitronectin and laminin; and

a culture medium, the culture medium comprising albumin, minerals, vitamins, amino acids, glucose, a fibroblast growth factor, lipids, a transferrin or a transferrin substitute, insulin or an insulin substitute, and at least two members selected from gamma amino butyric acid, pipecholic acid, and lithium in sufficient amounts to maintain the stem cells in an undifferentiated state through multiple culture passages, the medium being free of feeder cells and never having been exposed to feeder cells.

7. A method of culturing new human embryonic stem cells comprising the steps of

(a) isolating the inner cell mass of an embryo in the blastocyst stage;

(b) culturing the cells from step (a) in a medium including albumin, minerals, vitamins, amino acids, glucose, a fibroblast growth factor, gamma amino butyric acid, pipecholic acid, lithium, lipids, a transferrin or a transferrin substitute and insulin or an insulin substitute in sufficient amounts to maintain the stem cells in an undifferentiated state through multiple culture passages, the culturing step being conducted on a matrix of human proteins comprising at least three of the proteins selected from collagen, fibronectin, vitronectin, and laminin; and

(c) serially expanding the new cells which proliferate on the medium.

8. A culture of cells comprising human embryonic stem cells growing on a matrix of human proteins that comprises at least three of the proteins selected from collagen, fibronectin, vitronectin, and laminin, the stem cells from a lineage which has never been exposed to animal cells, animal proteins, feeder cells or conditioned medium, the cell culture medium comprising albumin, minerals, vitamins, amino acids, glucose, a fibroblast growth factor, gamma amino butyric acid, pipecholic acid, lithium, lipids, a transferrin or a transferrin substitute, and insulin or an insulin substitute capable of maintaining the cells through over twenty passages in culture while the cells remain undifferentiated, maintain pluripotency and maintain normal karyotype.

9. A culture of cells comprising human embryonic stem cells which do not exhibit the sialic acid Neu5Gc, wherein the culture comprises (i) human embryonic stem cells on a matrix of human proteins that comprises at least three of collagen, fibronectin, vitronectin, or lamiin and (ii) a cell culture medium that comprises albumin, minerals, vitamins, amino acids, glucose, a fibroblast growth factor, lipids, a transferrin or a transferrin substitute, insulin or an insulin substitute, and at least two members selected from gamma amino butyric acid, pipecholic acid, and lithium.

Assignments (4)
CONFIRMATORY LICENSE Recorded Dec 18, 2008
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022003/0893 →
CORRECTIVE ASSIGNMENT TO RE-RECORD ASSIGNMENT PREVIOUSLY RECORDED UNDER REEL AND FRAME 017018/0863 TO CORRECT FIRST ASSIGNOR'S DOC DATE 12/08/2005 TO 12/28/2005. Recorded Feb 9, 2007
From: LUDWIG, TENNEILLE E.; THOMSON, JAMES A.
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 018877/0621 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2006
From: LUDWIG, TENNEILLE E.; THOMSON, JAMES A.
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 017820/0355 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2006
From: LUDWIG, TENNEILLE E.; THOMSON, JAMES A.
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 017018/0863 →
Continuity (3)
Provisional Application 6069510000 · Jun 29, 2005
Provisional Application 6060804000 · Sep 8, 2004
Related Publication 20070238170A1 · Oct 11, 2007